Your browser doesn't support javascript.
loading
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
McKinlay, Mark A; Collett, Marc S; Hincks, Jeffrey R; Oberste, M Steven; Pallansch, Mark A; Okayasu, Hiromasa; Sutter, Roland W; Modlin, John F; Dowdle, Walter R.
Afiliação
  • McKinlay MA; Center for Vaccine Equity, The Task Force for Global Health, Decatur, Georgia ViroDefense Inc., Rockville, Maryland Centers for Disease Control and Prevention, Atlanta, Georgia World Health Organization, Geneva, Switzerland Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire Center for Va
  • Collett MS; ViroDefense Inc., Rockville, Maryland.
  • Hincks JR; ViroDefense Inc., Rockville, Maryland.
  • Oberste MS; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Pallansch MA; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Okayasu H; World Health Organization, Geneva, Switzerland.
  • Sutter RW; World Health Organization, Geneva, Switzerland.
  • Modlin JF; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
  • Dowdle WR; Center for Vaccine Equity, Task Force for Global Health, Decatur, Georgia.
J Infect Dis ; 210 Suppl 1: S447-53, 2014 Nov 01.
Article em En | MEDLINE | ID: mdl-25316866

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Poliomielite / Eliminação de Partículas Virais / Poliovirus / Erradicação de Doenças Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Poliomielite / Eliminação de Partículas Virais / Poliovirus / Erradicação de Doenças Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article